Altura Medical, Inc., a San Clemente, CA-based early stage medical device manufacturer, has completed a $20m Series A financing.
The round was led by New Leaf Venture Partners, with participation from new investor Advanced Technology Ventures, and existing investor SV Life Sciences.
The company is focused on devices and methods for the treatment of Abdominal Oortic Aneurysms (AAA). According to data, approximately 4.5 million people are living with an abdominal aortic aneurysm in the developed world (1.5 million in the U.S.) and each year 600,000 new cases are diagnosed (250,000 in the U.S.). Patients typically have no symptoms and when they are diagnosed, they often undergo complex surgical repair. Endovascular therapy provides a minimally invasive alternative, with reduced recovery times and improved survival rates.